Plant-based meatballs produced by Zhenmeat are seen at the counter as customers choose the ingredients for their meal at a Hope Tree restaurant in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Customers choose the ingredients for their meal at a Hope Tree restaurant which is offering plant-based meatballs produced by Zhenmeat in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Customers choose the ingredients for their meal at a Hope Tree restaurant which is offering plant-based meatballs produced by Zhenmeat in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Plant-based meatballs produced by Zhenmeat are seen at the counter as customers choose the ingredients for their meal at a Hope Tree restaurant in Beijing, China September 4, 2020. Picture taken September 4, 2020. REUTERS/Carlos Garcia Rawlins

Sacks of feed ingredients are seen inside a feed plant of the New Hope Liuhe in Xichang, during a government-organised media tour in Liangshan Yi Autonomous Prefecture, Sichuan province, China September 11, 2020. Picture taken September 11, 2020. REUTERS/Tingshu Wang

Salma Zu'bi, founder of the Atan soap brand, mixes the ingredients, which include donkey's milk, used to make her soap, at Salma's lab in Amman, Jordan August 30, 2020. Picture taken August 30, 2020. REUTERS/Muhammad Hamed

Imad, son of the founder of the Atan soap brand Salma Zu'bi, mixes the ingredients, which include donkey's milk, used to make their soap, at Salma's lab in Amman, Jordan August 30, 2020. Picture taken August 30, 2020. REUTERS/Muhammad Hamed

Salma Zu'bi, founder of the Atan soap brand, and her son Imad mix ingredients used to make their soap, at Salma's lab in Amman, Jordan August 30, 2020. Picture taken August 30, 2020. REUTERS/Muhammad Hamed

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, delivers a speech as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

Bruno Le Maire, French Minister of the Economy, Finance, and Recovery, wearing a protective face mask, talks to employees as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with employees as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron and Bruno Le Maire, French Minister of the Economy, Finance, and Recovery, wearing protective face masks, talk to employees as they visit a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron and Bruno Le Maire, French Minister of the Economy, Finance, and Recovery, wearing protective face masks, talk to employees as they visit a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with employees as he visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

French President Emmanuel Macron, wearing a protective face mask, visits a site of pharmaceutical group Seqens, a global leader on the production of active pharmaceutical ingredients, to mobilize innovation and support the research on the coronavirus disease (COVID-19), in Villeneuve-la-Garenne, near Paris, France August 28, 2020. REUTERS/Christian Hartmann/Pool

Nagwa Fathi, an Egyptian chef and founder of the "We are with You" campaign, tests a mix of honey with sour ingredients, part of nutritious meals for medical staff at hospitals struggling with the outbreak of the coronavirus disease (COVID-19), in Cairo, Egypt July 1, 2020. Picture taken July 1, 2020. REUTERS/Amr Abdallah Dalsh

Hawker Kristen Choong wears a protective mask as she prepares ingredients with her mother Lai Yau Kiew at their Hong Lim Hawker Centre stall, amid the coronavirus disease (COVID-19) outbreak in Singapore May 10, 2020. Picture taken May 10, 2020. REUTERS/Joseph Campbell

Food and condiments are displayed as a cafe has turned to selling off its ingredients outside, after customers are no longer allowed inside, as New South Wales begins shutting down non-essential businesses and moving toward harsh penalties to enforce self-isolation to avoid the spread of coronavirus disease (COVID-19) in Sydney, Australia, March 25, 2020. REUTERS/Loren Elliott

Members of All India Hindu Mahasabha serve a traditional drink with cow urine as an ingredient during a gaumutra (cow urine) party, which according to them helps in warding off coronavirus disease (COVID-19), in New Delhi, India March 14, 2020. REUTERS/Danish Siddiqui

Ingredients for 18-carat alloy are pictured at Swiss refinery Metalor in Marin near Neuchatel, Switzerland July 5, 2019. Picture taken July 5, 2019. To match Special Report GOLD-PERU/SWISS REUTERS/Denis Balibouse

A vegan beef steak is 3D printed at the Culinary School of Barcelona, Spain February 25, 2020. The syringe dispenses plant-based ingredients in thin lines to build up a fibrous structure that resembles a regular piece of meat. Picture taken February 25, 2020. REUTERS/Nacho Doce

A 3D printed vegan beef steak is pictured at the Culinary School of Barcelona, Spain February 25, 2020. The syringe dispenses plant-based ingredients in thin lines to build up a fibrous structure that resembles a regular piece of meat. Picture taken February 25, 2020. REUTERS/Nacho Doce

Devotees stand in line to collect utensils and ingredients for preparing ritual rice dishes to offer to the Hindu Sun God as they attend Pongal celebrations at a slum in Mumbai, India, January 15, 2020. REUTERS/Francis Mascarenhas

Devotees stand in line to collect utensils and ingredients for preparing ritual rice dishes to offer to the Hindu Sun God as they attend Pongal celebrations at a slum in Mumbai, India, January 15, 2020. REUTERS/Francis Mascarenhas

A pastry bag, sandwich and tissue boxes on display featuring MarinaTex - an edible and compostable plastic alternative made from byproducts of the fishing industry and other natural ingredients which has won the James Dyson Award, in Brighton, Britain, October 24, 2019. Picture taken October 24, 2019. REUTERS/ Stuart McDill

A pastry bag, sandwich and tissue boxes on display featuring MarinaTex - an edible and compostable plastic alternative made from byproducts of the fishing industry and other natural ingredients which has won the James Dyson Award, in Brighton, Britain, October 24, 2019. Picture taken October 24, 2019. REUTERS/ Stuart McDill

Product design graduate Lucy Hughes holds up a sheet of MarinaTex - an edible and compostable plastic alternative made from byproducts of the fishing industry and other natural ingredients which has won the James Dyson Award, in Brighton, Britain, October 24, 2019. Picture taken October 24, 2019. REUTERS/ Stuart McDill

Product design graduate Lucy Hughes holds up a sheet of MarinaTex - an edible and compostable plastic alternative made from byproducts of the fishing industry and other natural ingredients which has won the James Dyson Award, in Brighton, Britain, October 24, 2019. Picture taken October 24, 2019. REUTERS/ Stuart McDill

Britain's Prime Minister Boris Johnson examines a selection of ingredients used in whisky making, during a general election campaign visit to Diageo's Roseisle Distillery near Elgin, Scotland, Britain November 7, 2019. Daniel Leal-Olivas/Pool via REUTERS

Britain's Prime Minister Boris Johnson examines a selection of ingredients used in whisky making, during a general election campaign visit to Diageo's Roseisle Distillery near Elgin, Scotland, Britain November 7, 2019. Daniel Leal-Olivas/Pool via REUTERS

Britain's Prime Minister Boris Johnson (L) and and accompanied by Conservative party candidate for Moray, Douglas Ross, look at a selection of ingredients used in whisky making, during a general election campaign visit to Diageo's Roseisle Distillery near Elgin, Scotland, Britain November 7, 2019. Daniel Leal-Olivas/Pool via REUTERS

A worker from New Hope Liuhe displays pig feed ingredient for media at the company's feed plant in Ho Chi Minh city, Vietnam August 25, 2019. Picture taken August 25, 2019. REUTERS/Hallie Gu